Additionally, AD-MSC transplants have also demonstrated success in experimental ischemic stroke models, in which animals treated with AD-MSCs demonstrated increased expression of BDNF and enhanced nerve regeneration, and simultaneously reduced expression of pro-apoptotic proteins such as BCL-2 and BAX within the ischemic lesion (Li et al., 2016). This evidence concerns the gene BCL2 and Alzheimer disease.